JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis

Condition:   Erosive Esophagitis Interventions:   Drug: Experimental drug;   Drug: Active comparative drug Sponsor:   Onconic Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials